OncoPEP's Series A Round

OncoPEP raised a round of funding on May 23, 2011.

ONCoPEP is developing targeted immunotherapies to prevent the progression of cancer, prolong survival and restore the quality of life of patients. ONCoPEP's lead program, PVX-410, is a multi-peptide t…

Articles about OncoPEP's Series A Round: